- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Apollo to retool imaging portfolio
Investment firm Apollo Management is restructuring its holdings in the imaging services segment by arranging to have its Alliance Imaging unit acquire SMT Health Services, another mobile imaging provider that Apollo owns. Alliance of Anaheim, CA,
Investment firm Apollo Management is restructuring its holdings in the imaging services segment by arranging to have its Alliance Imaging unit acquire SMT Health Services, another mobile imaging provider that Apollo owns. Alliance of Anaheim, CA, announced on April 15 that it will acquire Pittsburgh-based SMT in a stock-for-stock merger in which Alliance will assume responsibility for $68.4 million in SMT debt.
New York City-based Apollo has been intent on consolidating the mobile imaging segment, and bought SMT in 1997 and Alliance in 1998 (SCAN 7/9/97 and 1/14/98). Apollo originally operated the two firms as separate entities in order to maintain Alliances favorable tax status, but apparently now sees advantages to running them both under Alliances umbrella. Following the acquisition, Alliance will operate about 285 MRI scanners across the U.S. Alliance executives were not available for comment on the deal.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
